Cargando…

Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein

The etiology of Parkinson’s disease is poorly understood and is most commonly associated with advancing age, genetic predisposition, or environmental toxins. Epidemiological findings suggest that patients have a higher risk of developing Parkinson’s disease after ischemic stroke, but this potential...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lohmann, Stephanie, Grigoletto, Jessica, Bernis, Maria Eugenia, Pesch, Verena, Ma, Liang, Reithofer, Sara, Tamgüney, Gültekin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867857/ https://www.ncbi.nlm.nih.gov/pubmed/35209932 http://dx.doi.org/10.1186/s40478-022-01327-6

Ejemplares similares

Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein
por: Bernis, Maria E., et al.
Publicado: (2015)

Oral and intravenous transmission of α-synuclein fibrils to mice
por: Lohmann, Stephanie, et al.
Publicado: (2019)

Neuroinvasion of α-Synuclein Prionoids after Intraperitoneal and Intraglossal Inoculation
por: Breid, Sara, et al.
Publicado: (2016)

Seeding and transgenic overexpression of alpha‐synuclein triggers dendritic spine pathology in the neocortex
por: Blumenstock, Sonja, et al.
Publicado: (2017)

Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats
por: Van Den Berge, Nathalie, et al.
Publicado: (2021)

Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson’s disease
por: Niu, Haichen, et al.
Publicado: (2018)

Alpha-Synuclein and Parkinson’s Disease Motor and Non-Motor Symptoms: What Is New?
por: Grigoletto, Jessica, et al.
Publicado: (2022)

Spinal Cord Pathology in Alpha-Synuclein Transgenic Mice
por: Mendritzki, Sonja, et al.
Publicado: (2010)

A Bioluminescent Cell Assay to Quantify Prion Protein Dimerization
por: Wüsten, Katharina Annick, et al.
Publicado: (2018)

Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson’s Disease
por: Fitzgerald, Emily, et al.
Publicado: (2019)

Retraction Note: Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson’s disease
por: Niu, Haichen, et al.
Publicado: (2022)

Modeling Parkinson's disease‐related symptoms in alpha‐synuclein overexpressing mice
por: Aniszewska, Agata, et al.
Publicado: (2022)

Gastrointestinal Biopsies for the Diagnosis of Alpha-Synuclein Pathology in Parkinson's Disease
por: Cersosimo, Maria Graciela
Publicado: (2015)

GI infections are associated with an increased risk of Parkinson’s disease
por: Nerius, Michael, et al.
Publicado: (2020)

Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats
por: Van Den Berge, Nathalie, et al.
Publicado: (2019)

Identifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson’s Disease
por: Shen, Ning, et al.
Publicado: (2019)

Increased telomerase improves motor function and alpha-synuclein pathology in a transgenic mouse model of Parkinson’s disease associated with enhanced autophagy
por: Wan, Tengfei, et al.
Publicado: (2021)

Loss of Corticostriatal Mu-Opioid Receptors in α-Synuclein Transgenic Mouse Brains
por: Grigoletto, Jessica, et al.
Publicado: (2022)

Hypoxia and Alpha-Synuclein: Inextricable Link Underlying the Pathologic Progression of Parkinson's Disease
por: Guo, Mengyuan, et al.
Publicado: (2022)

Transmission of alpha-synuclein in Parkinson’s disease
por: Lee, Virginia M-Y
Publicado: (2013)

Alpha-synuclein spreading in Parkinson’s disease
por: Recasens, Ariadna, et al.
Publicado: (2014)

Alpha-Synuclein Aggregation in Parkinson's Disease
por: Srinivasan, E., et al.
Publicado: (2021)

Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease
por: Kaul, Tiffany, et al.
Publicado: (2011)

Age-dependent alpha-synuclein accumulation and aggregation in the colon of a transgenic mouse model of Parkinson’s disease
por: Chen, Qian-Qian, et al.
Publicado: (2018)

Administration of AAV-Alpha Synuclein NAC Antibody Improves Locomotor Behavior in Rats Overexpressing Alpha Synuclein
por: Chen, Yun-Hsiang, et al.
Publicado: (2021)

Patients with isolated REM-sleep behavior disorder have elevated levels of alpha-synuclein aggregates in stool
por: Schaffrath, Anja, et al.
Publicado: (2023)

Effects of α-Synuclein Overexpression in Transgenic Caenorhabditis elegans Strains
por: Bodhicharla, Rakesh, et al.
Publicado: (2012)

PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson’s Disease
por: Li, Wen, et al.
Publicado: (2021)

Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
por: Sekiya, Hiroaki, et al.
Publicado: (2022)

Impaired Baroreflex Function in Mice Overexpressing Alpha-Synuclein
por: Fleming, Sheila M., et al.
Publicado: (2013)

Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
por: Gómez-Benito, Mónica, et al.
Publicado: (2020)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
por: Fan, Tian-Sin, et al.
Publicado: (2021)

Nigral overexpression of alpha-synuclein in the absence of parkin enhances alpha-synuclein phosphorylation but does not modulate dopaminergic neurodegeneration
por: Van Rompuy, Anne-Sophie, et al.
Publicado: (2015)

Peptide immunization against the C-terminal of alpha-synuclein reduces locomotor activity in mice overexpressing alpha-synuclein
por: Chiu, Yu-Sung, et al.
Publicado: (2023)

Overexpression of Wild-Type Human Alpha-Synuclein Causes Metabolism Abnormalities in Thy1-aSYN Transgenic Mice
por: Cuvelier, Elodie, et al.
Publicado: (2018)

Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype
por: Faustini, Gaia, et al.
Publicado: (2022)

Alpha-Synuclein as a Pathological Link Between Chronic Traumatic Brain Injury and Parkinson's Disease
por: Acosta, Sandra A, et al.
Publicado: (2015)

Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson’s disease brain
por: Roberts, Rosalind F., et al.
Publicado: (2015)

Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson’s disease
por: Cai, Waijiao, et al.
Publicado: (2022)

Alpha-synuclein oligomers and small nerve fiber pathology in skin are potential biomarkers of Parkinson’s disease
por: Vacchi, Elena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4td3j7tfre0g929efn639adq16